COMPARISON OF ALPHA BLOCKERS IN TREATMENT OF PREMATURE EJACULATION: A PILOT CLINICAL TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AKIN YIGIT; GULMEZ HAKAN; ATES MUTLU; BOZKURT ALISEYDI; BARIS NUHOGLU

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Red Crescent Medical Journal Year:2013 | Volume:15 | Issue:10 Page(s): 0-0

Download Full-Text

View:

399

Download:

213

Cites:

Information Journal Paper

Title

COMPARISON OF ALPHA BLOCKERS IN TREATMENT OF PREMATURE EJACULATION: A PILOT CLINICAL TRIAL

Author(s)

Keywords

PREMATURE EJACULATION

QUALITY OF LIFE

SEROTONIN UPTAKE INHIBITORS

Abstract

Background: PREMATURE EJACULATION (PE) is the most common sexual disorder in men and studies reported prevalence up to 30% (1, 2). PE is not a life-threatening medical condition but it influences the QUALITY OF LIFE (QoL).Objective: The aim of this study was to compare the efficiency, and safety of alpha blocker drugs in the treatment of patients with PREMATURE EJACULATION (PE). Additionally we investigated the QUALITY OF LIFE (QoL) in patients with PE who were treated with alpha blocker drugs.Materials and Methods: This study was a pilot clinical trial. Prospectively documented 108 patients with PE were treated and were followed-up in urology outpatient clinic. All patients were divided into 5 groups according to used alpha blocker agents which were determined by simple randomization. Silodosin 4mg (Group 1, n=21), tamsulosin hydrochloride 0.4mg (Group 2, n=23), alfuzosin 10mg (Group 3,n=22), terazosin 5mg (Group 4, n=21), doksazosin mesylate 4mg (Group5, n=21), were used for treatment. The demographic parameters of patients, pre and post treatment intravaginal ejaculation latency time (IELT), PE Profile (PEP), and QoL index were recorded and evaluated. Effectiveness of treatment was evaluated by measuring IELT. Additionally, side effects of drugs were recorded. P<0.05 was considered statistically significant.Results: All alpha blocker drugs were statistically effective for preventing PE. Notably, silodosin seemed to be more effective for preventing PE than other alpha blockers (P<0.05). However all alpha blockers provided development in QoL scores, silodosin was a little better than other drugs in statistical analyses. Furthermore statistical increase in IELT and decrease in PEP were provided more in Group 1 than other groups (P<0.05).Conclusions: Silodosin seems to be able to even more prevent PE. Silodosin may provide development in QoL than other alpha blocker agents. Additionally, lower systemic adverse events and more effectivity are the prominent features of silodosin in PE.This study was a pilot clinical trial. Prospectively documented 108 patients with PE were treated and were followed-up in urology outpatient clinic. All patients were divided into 5 groups according to used alpha blocker agents which were determined by simple randomization. Silodosin 4mg (Group 1, n=21), tamsulosin hydrochloride 0.4mg (Group 2, n=23), alfuzosin 10mg (Group 3, n=22), terazosin 5mg (Group 4, n=21), doksazosin mesylate 4mg (Group5, n=21), were used for treatment. The demographic parameters of patients, pre and post treatment intravaginal ejaculation latency time (IELT), PE Profile (PEP), and QoL index were recorded and evaluated. Effectiveness of treatment was evaluated by measuring IELT. Additionally, side effects of drugs were recorded. P<0.05 was considered statistically significant.

Cites

No record.

References

No record.

Cite

APA: Copy

AKIN, YIGIT, GULMEZ, HAKAN, ATES, MUTLU, BOZKURT, ALISEYDI, & BARIS, NUHOGLU. (2013). COMPARISON OF ALPHA BLOCKERS IN TREATMENT OF PREMATURE EJACULATION: A PILOT CLINICAL TRIAL. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 15(10), 0-0. SID. https://sid.ir/paper/292749/en

Vancouver: Copy

AKIN YIGIT, GULMEZ HAKAN, ATES MUTLU, BOZKURT ALISEYDI, BARIS NUHOGLU. COMPARISON OF ALPHA BLOCKERS IN TREATMENT OF PREMATURE EJACULATION: A PILOT CLINICAL TRIAL. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2013;15(10):0-0. Available from: https://sid.ir/paper/292749/en

IEEE: Copy

YIGIT AKIN, HAKAN GULMEZ, MUTLU ATES, ALISEYDI BOZKURT, and NUHOGLU BARIS, “COMPARISON OF ALPHA BLOCKERS IN TREATMENT OF PREMATURE EJACULATION: A PILOT CLINICAL TRIAL,” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 15, no. 10, pp. 0–0, 2013, [Online]. Available: https://sid.ir/paper/292749/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops